Insights on injection technique and the future potential of SCS treatments.
Dilraj S. Grewal, MD, FASRS
Advertisement
Articles by Dilraj S. Grewal, MD, FASRS
Ophthalmologist Dilraj Grewal explores cutting-edge clinical trials for uveitis treatment, highlighting new targeted therapies that aim to control inflammation and macular edema with fewer steroid-related side effects.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Leadership in action during the 2025 AAO named lectures
2
AAO 2025: Ashkan Abbey on the outcomes of EYP-1901 for AMD and DME
3
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
4
Empowerment through education: Q&A with Inder Paul Singh, MD
5
